NCT03931681View on ClinicalTrials.gov

A Study of OKI-179 in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 8, 2019

Primary Completion Date

November 27, 2021

Study Completion Date

November 27, 2021

Conditions
Advanced Solid Tumors
Interventions
DRUG

OKI-179

OKI-179 single agent

Trial Locations (1)

80045

University of Colorado Cancer Center, Aurora

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

lead

OnKure, Inc.

INDUSTRY

NCT03931681 - A Study of OKI-179 in Patients With Solid Tumors | Biotech Hunter | Biotech Hunter